DIGITAL HEALTH BRIEFING: Novartis, Pear Therapeutics partner to improve digital offerings - Heart app saved Johns Hopkins over $200K - Medical logistics platform raises $5M
NOVARTIS STRENGTHENS ITS DIGITAL OFFERINGS WITH PEAR THERAPEUTICS PARTNERSHIP: Novartis, the Swiss drugmaker, is partnering with prescription digital therapeutic firm Pear Therapeutics to improve the treatment of schizophrenia and multiple sclerosis (MS). The partnership between the two companies will focus on product development and design, specifically digital products that can be prescribed alongside Novartis' medication.
- Novartis will aid in the development of Pear's Thrive product for patients with schizophrenia. The digital therapeutic provides cognitive behavior therapy to patients via mobile and desktop applications. This includes real-time interventions targeting positive symptoms of schizophrenia, such as hallucinations and delusions, and also provides support for schizophrenia-related mood disorders. The solution, which can be prescribed alongside drug therapies, has received positive results in three clinical trials.
- The firms will jointly design a new digital solution to address mental health conditions, such as depression, suffered by MS patients. Most treatments for MS focus on mobility symptoms but don't address peripheral conditions, such as the depression, anxiety, fatigue, and cognitive impairment, that patients encounter. A combination of drugs and digital therapeutics that address both the physical and mental symptoms is the best way to treat patients, Novartis head of digital therapeutics Joris Van Dam told MobiHealthNews.
The partnership will aid Novartis' move beyond pill-based therapeutics and towards health management. Providers are increasingly turning to digital health services, and Novartis is padding its offerings with digital services to differentiate from the competition and make it more attractive to clients. The drugmaker is one of the most active investors in healthcare technologies, including telemedicine platforms, point-of-care diagnostics, and oncology therapeutics, according to CB Insights.The Novartis and Pear Therapeutics partnership follows a trend that has been a growing within big pharma. Pharmaceutical companies are looking more to outcome-based solutions as the healthcare industry moves to value-based care model. This involves the adoption of digital health technology to increase engagement with patients to improve care and medication adherence. For example, Merck KGaA recently partnered with North American digital therapeutics company Blue Mesa Health to pilot Diabetes Prevention Programs. Merck KGaA was already seen as a leader in diabetic medicine, but this new partnership will allow the firm to offer providers new solutions to stay better connected with patients and improve overall care. The global digital therapeutics market size is expected to grow from $1.7 billion in 2016 to $9.4 billion by 2025, according to Grand View Research.
AI-FUELED MEDICAL LOGISTICS PLATFORM RAISES $5 MILLION: Tagnos raised $5 million in funding for its AI-powered hospital logistics platform, according to MobiHealthNews. The platform combines data from real-time location systems (RTLS), such as electronic health records and computerized physician order entry (CPOE) systems, to improve the flow of patients within the hospital or clinic. The platform can identify patterns that might indicate a logistical bottleneck and alert staff. Solutions such as Tagnos' platform are helping to address an increasingly expensive pitfall in hospital and clinical workflows. Poor communication between departments costs the average US hospital around $1.75 million annually, according to Spyglass Consulting. The continued adoption of mobile technology by hospital staff as well as advances in connected technology is giving healthcare organizations the opportunity to address these issues, either through platform solutions, or through the higher usage of healthcare-focused mobile devices. By 2022, 97% of bedside nurses and 98% of physicians expect to be using mobile devices in the hospital setting, according to Zebra Technologies. That's up from 65% of bedside nurses and 51% of physicians in 2017.
HELIX GETS $200 MILLION IN FUNDING AS IT AIMS TO GROW ITS MARKETPLACE: Helix, the California-based consumer genetics startup, raised $200 million to expand its DNA marketplace, according to TechCrunch. Helix differentiates itself from most consumer genetic firms because it doesn't develop actual tests, rather, the firm developed a marketplace for companies to sell their services on. After Helix collects and sequences a user's DNA sample, it then stores that data so a user can share that data with genetic test companies. Users can pick different products, such as National Geographic's genetic test, straight from the marketplace without the hassle of having to provide a whole new saliva sample. The marketplace, which currently includes 35 products, is expected to more than double its offerings by the end of 2018, as a result of this latest investment. Helix has reported early success - 20% of its customers who bought one product ended up buying a second. The firm's likely hoping to capitalize on a significant opportunity - the global direct-to-consumer genetic testing market is projected to grow at a compound annual growth rate of 20%, from $117 million in 2017 $ 611 million by 2026, according to Credence Research.In other news…
- Travis Kalanick, the co-founder and former CEO of Uber, is joining the board of Kareo, a medical software company the provides independent medical practices with cloud computing products and services for electronic health records, practice management and bill paying, Axios reports. Kalanick was an angel investor in Kareo, which has surpassed $70 million in annual revenue.
EXCLUSIVE FREE REPORT:
The AI 101 Report by the Business Insider Intelligence Research Team.
Get the Report Now »
- 5-star rating refrigerator (fridge) in India
- Best soundbar with Dolby Atmos in India 2021
- Best soundbars with a wireless subwoofer
- Myntra signs up Hrithik Roshan, Vijay Deverakonda and Dulquer Salmaan as its newest brand ambassadors
- Google is now using Chrome as an added security layer for account sign-ins